维普中文期刊产品整合服务
44篇 您的检索式:作者名="Sydes"
    题名 作者 年代 出处 被引量
1Is Duplex Surveillance of Value After Leg Vein Bypass Grafting?: Principal Results of the Vein Graft Surveillance Randomised Trial (VGST)显示文摘A H. Davies A J. Hawdon M R. Sydes S G. Thompson 2005Circulation2005,,:2
2An international evaluation of CODOX - M and CODOX - M ahemating with IVAC in adult Burkitt's lymphoma:resuhs of United Kingdom Lymphoma Group LY06 study显示文摘Mead G Sydes M Walewski J 2002Ann Oncol2002,13,8:1
3An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study显示文摘Mead GM Sydes MR WalewskiJ 2002Ann Oncol2002,13,8:1
4Some tests for niche limitation by examination of species diversity in the Dunedin area 显示文摘Wilson J B Sydes M T 1988New Zealand N Z J Bat1988,26,:1
5Parameters for the Lyman Kutcher Burman(LKB)model of normal tissue complication probability(NTCP)for specific rectal complications observed in clinical practise显示文摘Gulliford S L Partridge M Sydes M R 2012Radiotherapy and Oncology2012,102,3:1
6Kinetics of adsorption and diffusional characteristics of carbon molecular sieves 显示文摘CHAGGER H K NDAJI F E SYDES M L 1995Carbon1995,33,10:1
7Escalateddose versus standard-dose conformal radiotherapy in pros- tate cancer: first results from the MRC RT01 randomised controlled trial 显示文摘Dearnaley DP Sydes MR Graham JD 2007Lancet Oncol2007,8,:1
8Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise显示文摘Gulliford SL Partridge M Sydes MR 2012Radiother Oncol2012,102,:1
9Escalated-doseversusstandard-doseconformalradiotherapyinprostatecanc-er:firstresultsfrom the MRC RT01randomisedcontrolledtrial显示文摘DearnaleyDP Sydes M R GrahamJD etal 2007LancetOncology2007,8,6:1
10Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer:the MRC STAMPEDE trial显示文摘Sydes MR Parmar MK James ND 2009Trials2009,10,:1
11Benefits of UV-curable Coatings显示文摘BRUEN K DAVIDSON K SYDES Daniel F E 2004European Coatings Journal2004,,4:1
12Escalated- dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RTO1 randomised controlled trial 显示文摘Dearnaley D P Sydes M R Graham J D 2007Lancet Oncol2007,8,6:1
13Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials显示文摘Gelderblom H Jinks RC Sydes M 2011Eur J Cancer2011,47,6:1
14Survival after recurrent osteosarcoma:data from 3 European Osteosarcoma Intergroup(EOI)randomized controlled trials显示文摘Gelderblom H Jinks RC Sydes M 2011Eur J Cancer2011,47,6:1
15Addition of docetaxel,zoledronic acid,or both to first-line longterm hormone therapy in prostate cancer(STAM-PEDE):survival results from an adaptive,multiarm,multistage,platform randomised controlled trial显示文摘James N D Sydes M R Clarke N W Lancet0,387,10024:1
16Is duplex surveillance of value after leg vein bypass grafting Principal results of the Vein Graft Surveillance Randomised Trial (VGST) 显示文摘Davies AH Hawdon A J Sydes MR 2005Circulation2005,112,13:1
17A quantitative analysis of shoot phenology and dominance in herbaceous vegetation显示文摘Al-Mufti M M Sydes C L Fumess S B 1977Joumal of Ecology1977,65,:1
18HIV western blot assay:What determines an indeterminate status? 显示文摘Syde IH Balakrishnan P Sunil S 2005Indian J Med Sci2005,59,10:1
19Consolidation radiothera- py in patients with advanced Hodgkin' s lymphoma: Survival data from the UKLG LY09 randomized controlled trial ( ISRCTN97144519 ) 显示文摘Johnson PW Sydes MR Hancock BW 2010J Clin Oncol2010,28,20:1
20Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin:a report from the European Osteosarcoma Intergroup显示文摘Mc Tiernan A Jinks RC Sydes MR 2012Eur J Cancer2012,48,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费